Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2014
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting
Luis Ostrosky-Zeichner, Shmuel Shoham, Jose Vazquez, et al.
The Journal of Infectious Diseases
|
August 8, 2009
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome
Nina Singh, Jose M Aguado, Hugo Bonatti, et al.
Obstetrics and Gynecology
|
December 11, 2025
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant Women
Allison Avrich Ciesla, Victoria Lazariu, Janet A Watts, et al.
JAMA Network Open
|
September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
Stephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 11, 2025
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025
Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.
JAMA Network Open
|
June 23, 2026
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design
Ryan E Wiegand, Sean Chickery, Duck-Hye Yang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023
Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
BMJ (Clinical Research Ed.)
|
October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Influenza and Other Respiratory Viruses
|
March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2014
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting
Luis Ostrosky-Zeichner, Shmuel Shoham, Jose Vazquez, et al.
The Journal of Infectious Diseases
|
August 8, 2009
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome
Nina Singh, Jose M Aguado, Hugo Bonatti, et al.
Obstetrics and Gynecology
|
December 11, 2025
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant Women
Allison Avrich Ciesla, Victoria Lazariu, Janet A Watts, et al.
JAMA Network Open
|
September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
Stephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 11, 2025
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025
Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.
JAMA Network Open
|
June 23, 2026
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design
Ryan E Wiegand, Sean Chickery, Duck-Hye Yang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023
Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
BMJ (Clinical Research Ed.)
|
October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Influenza and Other Respiratory Viruses
|
March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
Page
of 6